Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Ovarian Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Fallopian Tube Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Paclitaxel 3Docetaxel 3Watchful Waiting 2Tamoxifen 2Immunohistochemistry 2Goserelin 2Everolimus 2Cyclophosphamide 2Bevacizumab 2Anastrozole 2vandetanib 1pegfilgrastim 1lonafarnib 1exemestane 1Trastuzumab 1Sunitinib 1Psychiatric Rehabilitation 1Neoadjuvant Therapy 1Metformin 1Mental Status and Dementia Tests 1Leuprolide 1Letrozole 1Lapatinib 1High-Energy Shock Waves 1Gene Expression Profiling 1Doxorubicin 1Dasatinib 1Chemotherapy, Adjuvant 1Biopsy, Needle 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms, Male × Dasatinib × Clear all
NCT00410813 2017-07-02

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

SWOG Cancer Research Network

Phase 2 Completed
85 enrolled 18 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡